Share Price and Basic Stock Data
Last Updated: October 10, 2025, 1:53 am
| PEG Ratio | -1.83 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Morarka Finance Ltd, operating as a Non-Banking Financial Company (NBFC), reported a price of ₹96.5 and a market capitalization of ₹43.4 Cr. The company has shown fluctuating sales figures over recent quarters, with notable peaks observed in June 2022 (₹5.19 lakh) and June 2023 (₹5.13 lakh). However, sales dropped significantly in the following quarters, with a low of ₹0.01 lakh in March 2023. The trailing twelve months (TTM) revenue stands at ₹1.99 Cr, indicating a decline compared to the previous fiscal year. The operational efficiency is reflected in the operating profit margin (OPM), which stood at 51.72% in the latest quarter. This margin suggests that while the company has been able to maintain some profitability, the volatility in revenue indicates potential challenges in consistent revenue generation, typical for smaller NBFCs amidst a competitive landscape. The sales trajectory will require close monitoring to assess the impact of broader economic factors on future performance.
Profitability and Efficiency Metrics
Morarka Finance’s profitability metrics reveal a mixed performance. The company reported a net profit of ₹2.80 Cr for the fiscal year 2025, translating to an earnings per share (EPS) of ₹6.22. The return on equity (ROE) was recorded at 2.93%, while return on capital employed (ROCE) stood at 3.29%. These figures are relatively low when compared to industry benchmarks, suggesting that while the company generates profit, it may not be utilizing its equity and capital as effectively as its peers. The interest coverage ratio is not applicable, indicating that the company does not have any outstanding borrowings, which is a positive aspect in terms of financial risk. However, the cash conversion cycle remains at zero days, which can be interpreted as a sign of efficient cash management but may also highlight the lack of robust operational activities. Overall, while profitability exists, the efficiency metrics indicate areas for improvement to enhance returns on investments.
Balance Sheet Strength and Financial Ratios
The balance sheet of Morarka Finance shows a solid reserve position, with total reserves reported at ₹90.79 Cr and no borrowings, reflecting a debt-free status. This financial structure is advantageous as it limits financial risk and interest burden. The company’s price-to-book value (P/BV) ratio is low at 0.48x, suggesting that the stock may be undervalued relative to its book value. The liquidity ratios are exceptionally high, with a current ratio of 21693.05 and a quick ratio of 21645.64, indicating that the company has ample short-term assets to cover its liabilities. Such a strong liquidity position can provide a buffer against economic downturns. However, the significant drop in total assets from ₹269.86 Cr in FY 2022 to ₹96.19 Cr in FY 2025 raises concerns about the company’s asset management and operational efficiency. Investors should consider this dynamic when evaluating the company’s financial health.
Shareholding Pattern and Investor Confidence
Morarka Finance has a stable shareholding structure, with promoters holding 66.77% of the company as of March 2025, a slight increase from 65.98% in September 2022. The public holds 33.21% of the shares, reflecting a balanced distribution of ownership. The company has seen an increase in the number of shareholders, rising from 2,891 in March 2023 to 4,143 in March 2025, indicating growing investor interest. However, the absence of Foreign Institutional Investors (FIIs) and Domestic Institutional Investors (DIIs) may reflect a lack of confidence from larger investors regarding the company’s growth prospects. This could pose a risk if the company seeks significant capital for expansion or operational improvements. The high promoter holding can be seen as a strength, suggesting that the founding members are committed to the company’s long-term success, but it also raises concerns about the lack of diverse institutional backing.
Outlook, Risks, and Final Insight
If Morarka Finance can sustain its profitability margins while addressing the challenges of fluctuating revenues, it may enhance its competitive position in the NBFC sector. The absence of debt provides a unique opportunity for reinvestment in growth initiatives, which could lead to improved operational performance. However, risks such as dependency on a limited revenue stream and low institutional investment may hinder potential growth. The company needs to focus on diversifying its revenue sources and enhancing operational efficiencies to attract institutional interest. Additionally, maintaining robust liquidity while navigating changing market conditions will be crucial. If the company can leverage its strong balance sheet and improve its revenue consistency, it may set the stage for better profitability metrics and shareholder value in the future.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Morarka Finance Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Minolta Finance Ltd | 14.1 Cr. | 1.41 | 1.91/0.84 | 94.0 | 1.07 | 0.00 % | 0.40 % | 0.09 % | 1.00 |
| Money Masters Leasing & Finance Ltd | 12.1 Cr. | 1.21 | 15.6/1.06 | 19.0 | 1.31 | 0.00 % | 4.42 % | 3.94 % | 1.00 |
| Moneyboxx Finance Ltd | 578 Cr. | 177 | 285/130 | 79.8 | 0.00 % | 8.65 % | 0.58 % | 10.0 | |
| Moongipa Capital Finance Ltd | 17.7 Cr. | 19.3 | 41.0/17.5 | 13.3 | 24.9 | 0.00 % | 12.1 % | 9.43 % | 10.0 |
| Morarka Finance Ltd | 44.6 Cr. | 99.1 | 181/90.0 | 34.6 | 212 | 1.01 % | 2.46 % | 2.17 % | 10.0 |
| Industry Average | 31,244.63 Cr | 490.95 | 104.29 | 498.62 | 0.21% | 15.86% | 8.84% | 8.48 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.19 | 0.21 | 0.45 | 0.01 | 5.13 | 0.90 | 0.75 | 0.81 | 0.81 | 1.19 | 0.17 | 0.34 | 0.29 |
| Expenses | 0.11 | 0.06 | 0.11 | 0.10 | 0.13 | 0.08 | 0.13 | 0.12 | 0.13 | 0.11 | 0.15 | 0.16 | 0.14 |
| Operating Profit | 5.08 | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 0.68 | 1.08 | 0.02 | 0.18 | 0.15 |
| OPM % | 97.88% | 71.43% | 75.56% | -900.00% | 97.47% | 91.11% | 82.67% | 85.19% | 83.95% | 90.76% | 11.76% | 52.94% | 51.72% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 | 0.00 | 0.23 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 5.08 | 0.15 | 0.34 | -0.09 | 5.00 | 0.82 | 0.62 | 0.69 | 1.67 | 1.08 | 0.02 | 0.41 | 0.15 |
| Tax % | 3.54% | 93.33% | 38.24% | 366.67% | 3.80% | 25.61% | 40.32% | 23.19% | 1.80% | 50.00% | -400.00% | -26.83% | 0.00% |
| Net Profit | 4.89 | 0.00 | 0.21 | -0.43 | 4.81 | 0.61 | 0.37 | 0.53 | 1.64 | 0.54 | 0.09 | 0.52 | 0.14 |
| EPS in Rs | 10.86 | 0.00 | 0.47 | -0.96 | 10.68 | 1.35 | 0.82 | 1.18 | 3.64 | 1.20 | 0.20 | 1.16 | 0.31 |
Last Updated: July 18, 2025, 1:55 pm
Below is a detailed analysis of the quarterly data for Morarka Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 0.29 Cr.. The value appears to be declining and may need further review. It has decreased from 0.34 Cr. (Mar 2025) to 0.29 Cr., marking a decrease of 0.05 Cr..
- For Expenses, as of Jun 2025, the value is 0.14 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.16 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Jun 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.18 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.03 Cr..
- For OPM %, as of Jun 2025, the value is 51.72%. The value appears to be declining and may need further review. It has decreased from 52.94% (Mar 2025) to 51.72%, marking a decrease of 1.22%.
- For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.23 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.23 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.41 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.26 Cr..
- For Tax %, as of Jun 2025, the value is 0.00%. The value appears to be increasing, which may not be favorable. It has increased from -26.83% (Mar 2025) to 0.00%, marking an increase of 26.83%.
- For Net Profit, as of Jun 2025, the value is 0.14 Cr.. The value appears to be declining and may need further review. It has decreased from 0.52 Cr. (Mar 2025) to 0.14 Cr., marking a decrease of 0.38 Cr..
- For EPS in Rs, as of Jun 2025, the value is 0.31. The value appears to be declining and may need further review. It has decreased from 1.16 (Mar 2025) to 0.31, marking a decrease of 0.85.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 12:52 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.05 | 0.18 | 0.67 | 2.75 | 0.96 | 5.43 | 1.27 | 4.48 | 5.86 | 7.58 | 2.51 | 1.99 |
| Expenses | 0.32 | 0.22 | 0.33 | 0.45 | 0.37 | 0.42 | 0.45 | 0.36 | 0.42 | 0.38 | 0.46 | 0.56 | 0.56 |
| Operating Profit | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 | 1.43 |
| OPM % | -340.00% | -83.33% | 32.84% | 86.55% | 56.25% | 91.71% | 71.65% | 90.62% | 93.52% | 93.93% | 77.69% | 71.86% | |
| Other Income | 0.11 | 0.16 | 0.17 | 0.05 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 1.22 | 0.23 |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.24 | -0.01 | 0.02 | 0.27 | 2.38 | 0.54 | 4.98 | 0.92 | 4.06 | 5.48 | 7.12 | 3.17 | 1.66 |
| Tax % | -8.33% | 300.00% | 50.00% | 29.63% | 1.26% | 12.96% | 0.60% | 25.00% | 8.87% | 14.42% | 11.38% | 11.99% | |
| Net Profit | -0.21 | -0.04 | 0.01 | 0.18 | 2.34 | 0.47 | 4.95 | 0.69 | 3.69 | 4.68 | 6.32 | 2.80 | 1.29 |
| EPS in Rs | -0.47 | -0.09 | 0.02 | 0.40 | 5.20 | 1.04 | 10.99 | 1.53 | 8.20 | 10.40 | 14.04 | 6.22 | 2.87 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 19.23% | 95.74% | 0.00% | 65.22% | 48.78% | 48.08% | 42.72% | 16.07% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 80.95% | 125.00% | 1700.00% | 1200.00% | -79.91% | 953.19% | -86.06% | 434.78% | 26.83% | 35.04% | -55.70% |
| Change in YoY Net Profit Growth (%) | 0.00% | 44.05% | 1575.00% | -500.00% | -1279.91% | 1033.11% | -1039.25% | 520.84% | -407.95% | 8.21% | -90.74% |
Morarka Finance Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 48% |
| 5 Years: | -14% |
| 3 Years: | -18% |
| TTM: | -39% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 53% |
| 5 Years: | -11% |
| 3 Years: | -9% |
| TTM: | -59% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 34% |
| 5 Years: | 24% |
| 3 Years: | -12% |
| 1 Year: | -44% |
| Return on Equity | |
|---|---|
| 10 Years: | 3% |
| 5 Years: | 2% |
| 3 Years: | 3% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:51 pm
Balance Sheet
Last Updated: July 25, 2025, 1:01 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 | 4.50 |
| Reserves | 4.57 | 4.53 | 4.54 | 4.72 | 7.06 | 6.98 | 11.93 | 68.72 | 264.83 | 185.47 | 158.36 | 90.79 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.05 | 0.06 | 0.04 | 0.07 | 0.07 | 0.11 | 0.08 | 0.21 | 0.53 | 0.92 | 1.04 | 0.90 |
| Total Liabilities | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 |
| Fixed Assets | 0.09 | 0.09 | 0.08 | 0.08 | 0.07 | 0.07 | 0.07 | 0.06 | 0.06 | 0.06 | 0.05 | 0.05 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 8.61 | 8.61 | 8.61 | 8.88 | 11.11 | 11.09 | 13.79 | 72.86 | 269.00 | 189.81 | 162.92 | 95.23 |
| Other Assets | 0.42 | 0.39 | 0.39 | 0.33 | 0.45 | 0.43 | 2.65 | 0.51 | 0.80 | 1.02 | 0.93 | 0.91 |
| Total Assets | 9.12 | 9.09 | 9.08 | 9.29 | 11.63 | 11.59 | 16.51 | 73.43 | 269.86 | 190.89 | 163.90 | 96.19 |
Below is a detailed analysis of the balance sheet data for Morarka Finance Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 4.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 4.50 Cr..
- For Reserves, as of Mar 2025, the value is 90.79 Cr.. The value appears to be declining and may need further review. It has decreased from 158.36 Cr. (Mar 2024) to 90.79 Cr., marking a decrease of 67.57 Cr..
- For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 0.90 Cr.. The value appears to be improving (decreasing). It has decreased from 1.04 Cr. (Mar 2024) to 0.90 Cr., marking a decrease of 0.14 Cr..
- For Total Liabilities, as of Mar 2025, the value is 96.19 Cr.. The value appears to be improving (decreasing). It has decreased from 163.90 Cr. (Mar 2024) to 96.19 Cr., marking a decrease of 67.71 Cr..
- For Fixed Assets, as of Mar 2025, the value is 0.05 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.05 Cr..
- For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Investments, as of Mar 2025, the value is 95.23 Cr.. The value appears to be declining and may need further review. It has decreased from 162.92 Cr. (Mar 2024) to 95.23 Cr., marking a decrease of 67.69 Cr..
- For Other Assets, as of Mar 2025, the value is 0.91 Cr.. The value appears to be declining and may need further review. It has decreased from 0.93 Cr. (Mar 2024) to 0.91 Cr., marking a decrease of 0.02 Cr..
- For Total Assets, as of Mar 2025, the value is 96.19 Cr.. The value appears to be declining and may need further review. It has decreased from 163.90 Cr. (Mar 2024) to 96.19 Cr., marking a decrease of 67.71 Cr..
Notably, the Reserves (90.79 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.32 | -0.17 | -0.15 | 0.22 | 2.38 | 0.54 | 4.98 | 0.91 | 4.06 | 5.48 | 7.12 | 1.95 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventory Days | 5,840.00 | |||||||||||
| Days Payable | 0.00 | |||||||||||
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Working Capital Days | 1,095.00 | 344.72 | 92.61 | 43.80 | 91.25 | 16.80 | 57.48 | 13.85 | 10.59 | 13.00 | 16.00 | |
| ROCE % | -2.36% | -0.11% | 0.22% | 2.96% | 22.91% | 4.69% | 35.69% | 2.05% | 2.37% | 2.39% | 4.04% | 2.46% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Diluted EPS (Rs.) | 6.22 | 14.03 | 10.40 | 8.20 | 1.52 |
| Cash EPS (Rs.) | 6.22 | 14.04 | 10.40 | 8.21 | 1.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 211.65 | 361.74 | 421.96 | 598.23 | 162.63 |
| Dividend / Share (Rs.) | 1.00 | 6.00 | 5.00 | 4.00 | 1.00 |
| Revenue From Operations / Share (Rs.) | 5.55 | 16.85 | 13.01 | 9.96 | 2.81 |
| PBDIT / Share (Rs.) | 7.05 | 15.82 | 12.16 | 9.01 | 2.05 |
| PBIT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| PBT / Share (Rs.) | 7.04 | 15.81 | 12.16 | 9.00 | 2.04 |
| Net Profit / Share (Rs.) | 6.21 | 14.03 | 10.40 | 8.20 | 1.52 |
| PBDIT Margin (%) | 126.84 | 93.90 | 93.47 | 90.47 | 72.83 |
| PBIT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| PBT Margin (%) | 126.73 | 93.86 | 93.42 | 90.40 | 72.56 |
| Net Profit Margin (%) | 111.87 | 83.27 | 79.89 | 82.37 | 54.15 |
| Return on Networth / Equity (%) | 2.93 | 3.87 | 2.46 | 1.37 | 0.93 |
| Return on Capital Employeed (%) | 3.29 | 4.34 | 2.86 | 1.50 | 1.25 |
| Return On Assets (%) | 2.90 | 3.85 | 2.45 | 1.36 | 0.93 |
| Asset Turnover Ratio (%) | 0.01 | 0.04 | 0.02 | 0.02 | 0.02 |
| Current Ratio (X) | 21693.05 | 181301.78 | 135791.86 | 269365.90 | 93947.72 |
| Quick Ratio (X) | 21645.64 | 181069.67 | 135650.00 | 269194.10 | 93743.94 |
| Inventory Turnover Ratio (X) | 11.98 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 96.53 | 35.64 | 38.47 | 12.19 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 96.43 | 35.62 | 38.44 | 12.18 | 0.00 |
| Earning Retention Ratio (%) | 3.47 | 64.36 | 61.53 | 87.81 | 0.00 |
| Cash Earning Retention Ratio (%) | 3.57 | 64.38 | 61.56 | 87.82 | 0.00 |
| Enterprise Value (Cr.) | 45.95 | 66.44 | 47.61 | 46.14 | 14.39 |
| EV / Net Operating Revenue (X) | 18.37 | 8.76 | 8.13 | 10.29 | 11.38 |
| EV / EBITDA (X) | 14.48 | 9.33 | 8.69 | 11.38 | 15.62 |
| MarketCap / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.33 | 11.46 |
| Retention Ratios (%) | 3.46 | 64.35 | 61.52 | 87.80 | 0.00 |
| Price / BV (X) | 0.48 | 0.40 | 0.25 | 0.17 | 0.19 |
| Price / Net Operating Revenue (X) | 18.38 | 8.76 | 8.14 | 10.34 | 11.46 |
| EarningsYield | 0.06 | 0.09 | 0.09 | 0.07 | 0.04 |
After reviewing the key financial ratios for Morarka Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.22, marking a decrease of 7.81.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.22. This value is within the healthy range. It has decreased from 14.04 (Mar 24) to 6.22, marking a decrease of 7.82.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 211.65. It has decreased from 361.74 (Mar 24) to 211.65, marking a decrease of 150.09.
- For Dividend / Share (Rs.), as of Mar 25, the value is 1.00. This value is within the healthy range. It has decreased from 6.00 (Mar 24) to 1.00, marking a decrease of 5.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 5.55. It has decreased from 16.85 (Mar 24) to 5.55, marking a decrease of 11.30.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 7.05. This value is within the healthy range. It has decreased from 15.82 (Mar 24) to 7.05, marking a decrease of 8.77.
- For PBIT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For PBT / Share (Rs.), as of Mar 25, the value is 7.04. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 7.04, marking a decrease of 8.77.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.21. This value is within the healthy range. It has decreased from 14.03 (Mar 24) to 6.21, marking a decrease of 7.82.
- For PBDIT Margin (%), as of Mar 25, the value is 126.84. This value is within the healthy range. It has increased from 93.90 (Mar 24) to 126.84, marking an increase of 32.94.
- For PBIT Margin (%), as of Mar 25, the value is 126.73. This value exceeds the healthy maximum of 20. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For PBT Margin (%), as of Mar 25, the value is 126.73. This value is within the healthy range. It has increased from 93.86 (Mar 24) to 126.73, marking an increase of 32.87.
- For Net Profit Margin (%), as of Mar 25, the value is 111.87. This value exceeds the healthy maximum of 10. It has increased from 83.27 (Mar 24) to 111.87, marking an increase of 28.60.
- For Return on Networth / Equity (%), as of Mar 25, the value is 2.93. This value is below the healthy minimum of 15. It has decreased from 3.87 (Mar 24) to 2.93, marking a decrease of 0.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.29. This value is below the healthy minimum of 10. It has decreased from 4.34 (Mar 24) to 3.29, marking a decrease of 1.05.
- For Return On Assets (%), as of Mar 25, the value is 2.90. This value is below the healthy minimum of 5. It has decreased from 3.85 (Mar 24) to 2.90, marking a decrease of 0.95.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.01. It has decreased from 0.04 (Mar 24) to 0.01, marking a decrease of 0.03.
- For Current Ratio (X), as of Mar 25, the value is 21,693.05. This value exceeds the healthy maximum of 3. It has decreased from 181,301.78 (Mar 24) to 21,693.05, marking a decrease of 159,608.73.
- For Quick Ratio (X), as of Mar 25, the value is 21,645.64. This value exceeds the healthy maximum of 2. It has decreased from 181,069.67 (Mar 24) to 21,645.64, marking a decrease of 159,424.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 11.98. This value exceeds the healthy maximum of 8. It has increased from 0.00 (Mar 24) to 11.98, marking an increase of 11.98.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 96.53. This value exceeds the healthy maximum of 50. It has increased from 35.64 (Mar 24) to 96.53, marking an increase of 60.89.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 96.43. This value exceeds the healthy maximum of 50. It has increased from 35.62 (Mar 24) to 96.43, marking an increase of 60.81.
- For Earning Retention Ratio (%), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 40. It has decreased from 64.36 (Mar 24) to 3.47, marking a decrease of 60.89.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 3.57. This value is below the healthy minimum of 40. It has decreased from 64.38 (Mar 24) to 3.57, marking a decrease of 60.81.
- For Enterprise Value (Cr.), as of Mar 25, the value is 45.95. It has decreased from 66.44 (Mar 24) to 45.95, marking a decrease of 20.49.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 18.37. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.37, marking an increase of 9.61.
- For EV / EBITDA (X), as of Mar 25, the value is 14.48. This value is within the healthy range. It has increased from 9.33 (Mar 24) to 14.48, marking an increase of 5.15.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For Retention Ratios (%), as of Mar 25, the value is 3.46. This value is below the healthy minimum of 30. It has decreased from 64.35 (Mar 24) to 3.46, marking a decrease of 60.89.
- For Price / BV (X), as of Mar 25, the value is 0.48. This value is below the healthy minimum of 1. It has increased from 0.40 (Mar 24) to 0.48, marking an increase of 0.08.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 18.38. This value exceeds the healthy maximum of 3. It has increased from 8.76 (Mar 24) to 18.38, marking an increase of 9.62.
- For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 24) to 0.06, marking a decrease of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Morarka Finance Ltd:
- Net Profit Margin: 111.87%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.29% (Industry Average ROCE: 15.86%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 2.93% (Industry Average ROE: 8.84%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 21645.64
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 34.6 (Industry average Stock P/E: 104.29)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 111.87%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Non-Banking Financial Company (NBFC) | 511, Maker Chambers V, Mumbai Maharashtra 400021 | investors@morarkafinance.in http://www.morarkafinance.in |
| Management | |
|---|---|
| Name | Position Held |
| Mr. G R Morarka | Chairman |
| Ms. Priyanka G Morarka | Director |
| Ms. Divya Rao | Director |
| Mr. Arun Kumar Tulsian | Director |
| Ms. Nina Chatrath | Director |
| Ms. K Savitha Rao | Director |
FAQ
What is the intrinsic value of Morarka Finance Ltd?
Morarka Finance Ltd's intrinsic value (as of 09 October 2025) is 128.63 which is 29.80% higher the current market price of 99.10, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹44.6 Cr. market cap, FY2025-2026 high/low of 181/90.0, reserves of ₹90.79 Cr, and liabilities of 96.19 Cr.
What is the Market Cap of Morarka Finance Ltd?
The Market Cap of Morarka Finance Ltd is 44.6 Cr..
What is the current Stock Price of Morarka Finance Ltd as on 09 October 2025?
The current stock price of Morarka Finance Ltd as on 09 October 2025 is 99.1.
What is the High / Low of Morarka Finance Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Morarka Finance Ltd stocks is 181/90.0.
What is the Stock P/E of Morarka Finance Ltd?
The Stock P/E of Morarka Finance Ltd is 34.6.
What is the Book Value of Morarka Finance Ltd?
The Book Value of Morarka Finance Ltd is 212.
What is the Dividend Yield of Morarka Finance Ltd?
The Dividend Yield of Morarka Finance Ltd is 1.01 %.
What is the ROCE of Morarka Finance Ltd?
The ROCE of Morarka Finance Ltd is 2.46 %.
What is the ROE of Morarka Finance Ltd?
The ROE of Morarka Finance Ltd is 2.17 %.
What is the Face Value of Morarka Finance Ltd?
The Face Value of Morarka Finance Ltd is 10.0.